Tyra Biosciences, Inc.

The momentum for this stock is not very good. Tyra Biosciences, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Tyra Biosciences, Inc..
Log in to see more information.

News

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference

PR Newswire Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference PR Newswire CARLSBAD, Calif., Sept. 11, 2024...\n more…

Tyra Biosciences appoints Doug Warner as Chief Medical Officer
Tyra Biosciences appoints Doug Warner as Chief Medical Officer

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

PR Newswire Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer PR Newswire CARLSBAD, Calif., Sept. 10, 2024 -Dr. Warner...\n more…

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet
Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet

Zacks Investment Research Tyra Biosciences, Inc. (TYRA) closed the last trading session at $20.59, gaining 2.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set...\n more…

Tyra Biosciences (NASDAQ:TYRA) Research Coverage Started at Piper Sandler
Tyra Biosciences (NASDAQ:TYRA) Research Coverage Started at Piper Sandler

Ticker Report Research analysts at Piper Sandler began coverage on shares of Tyra Biosciences (NASDAQ:TYRA - Get Free Report) in a report issued on Thursday, MarketBeat.com reports. The brokerage set an...\n more…

Piper Sandler Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA)
Piper Sandler Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA)

Zolmax Investment analysts at Piper Sandler started coverage on shares of Tyra Biosciences (NASDAQ:TYRA - Get Free Report) in a report issued on Thursday, Marketbeat.com reports. The brokerage set an...\n more…